The ins and outs of MHC class II-mediated antigen processing and presentation

Nature Reviews Immunology

Volumn 15, Issue 4, 2015, Pages 203-216

  Roche, Paul A ^a   Furuta, Kazuyuki ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; AUTOPHAGY; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL MEMBRANE; CELLULAR DISTRIBUTION; DENDRITIC CELL; ENDOPLASMIC RETICULUM; GOLGI COMPLEX; HUMAN; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MULTIVESICULAR BODY; PHAGOCYTOSIS; PINOCYTOSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; UBIQUITINATION; ANIMAL; IMMUNOLOGY; METABOLISM; PROTEIN TRANSPORT;

ANTIGEN; EPITOPE; HLA ANTIGEN CLASS 2; PEPTIDE;

ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; ANTIGENS; CELL MEMBRANE; EPITOPES; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; PEPTIDES; PROTEIN TRANSPORT;

EID: 84925732779     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri3818     Document Type: Review

References (152)

1. Banchereau, J. et al. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767-811 (2000).
2. Harwood, N. E. & Batista, F. D. Early events in B cell activation. Annu. Rev. Immunol. 28, 185-210 (2010).
3. Trombetta, E. S. & Mellman, I. Cell biology of antigen processing in vitro and in vivo. Annu. Rev. Immunol. 23, 975-1028 (2005).
4. Blum, J. S., Wearsch, P. A. & Cresswell, P. Pathways of antigen processing. Annu. Rev. Immunol. 31, 443-473 (2013).
5. Bozzacco, L. et al. Mass spectrometry analysis and quantitation of peptides presented on the MHC II molecules of mouse spleen dendritic cells. J. Proteome Res. 10, 5016-5030 (2011).
6. Cresswell, P. Invariant chain structure and MHC class II function. Cell 84, 505-507 (1996).
7. Dugast, M., Toussaint, H., Dousset, C. & Benaroch, P. AP2 clathrin adaptor complex, but not AP1, controls the access of the major histocompatibility complex (MHC) class II to endosomes. J. Biol. Chem. 280, 19656-19664 (2005).
8. McCormick, P. J., Martina, J. A. & Bonifacino, J. S. Involvement of clathrin and AP-2 in the trafficking of MHC class II molecules to antigen-processing compartments. Proc. Natl Acad. Sci. USA 102, 7910-7915 (2005).
9. Roche, P. A., Teletski, C. L., Stang, E., Bakke, O. & Long, E. O. Cell surface HLA-DR-invariant chain complexes are targeted to endosomes by rapid internalization. Proc. Natl Acad. Sci. USA 90, 8581-8585 (1993).
10. Roche, P. A. & Cresswell, P. Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding. Nature 345, 615-618 (1990).
11. Castellino, F. & Germain, R. N. Extensive trafficking of MHC class II-invariant chain complexes in the endocytic pathway and appearance of peptide-loaded class II in multiple compartments. Immunity. 2, 73-88 (1995).
12. Neefjes, J. CIIV, MIIC and other compartments for MHC class II loading. Eur. J. Immunol. 29, 1421-1425 (1999).
13. Busch, R. et al. Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression. Immunol. Rev. 207, 242-260 (2005).
14. Denzin, L. K., Fallas, J. L., Prendes, M. & Yi, W. Right place, right time, right peptide: DO keeps DM focused. Immunol. Rev. 207, 279-292 (2005).
15. Lim, J. P. & Gleeson, P. A. Macropinocytosis: an endocytic pathway for internalising large gulps. Immunol. Cell Biol. 89, 836-843 (2011).
16. Mercer, J. & Helenius, A. Virus entry by macropinocytosis. Nature Cell Biol. 11, 510-520 (2009).
17. Clement, C. C., Rotzschke, O. & Santambrogio, L. The lymph as a pool of self-antigens. Trends Immunol. 32, 6-11 (2011).
18. Sallusto, F., Cella, M., Danieli, C. & Lanzavecchia, A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182, 389-400 (1995).
19. West, M. A. et al. Enhanced dendritic cell antigen capture via toll-like receptor-induced actin remodeling. Science 305, 1153-1157 (2004).
20. Garrett, W. S. et al. Developmental control of endocytosis in dendritic cells by Cdc42. Cell 102, 325-334 (2000).
21. Reis e Sousa, C., Stahl, P. D. & Austyn, J. M. Phagocytosis of antigens by Langerhans cells in vitro. J. Exp. Med. 178, 509-519 (1993).
22. Platt, C. D. et al. Mature dendritic cells use endocytic receptors to capture and present antigens. Proc. Natl Acad. Sci. USA 107, 4287-4292 (2010).
23. Young, L. J. et al. Dendritic cell preactivation impairs MHC class II presentation of vaccines and endogenous viral antigens. Proc. Natl Acad. Sci. USA 104, 17753-17758 (2007).
24. Drutman, S. B. & Trombetta, E. S. Dendritic cells continue to capture and present antigens after maturation in vivo. J. Immunol. 185, 2140-2146 (2010).
25. Rock, K. L., Benacerraf, B. & Abbas, A. K. Antigen presentation by hapten-specific B lymphocytes. I. Role of surface immunoglobulin receptors. J. Exp. Med. 160, 1102-1113 (1984).
26. Fearon, D. T. & Carroll, M. C. Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu. Rev. Immunol. 18, 393-422 (2000).
27. Antoniou, A. N. & Watts, C. Antibody modulation of antigen presentation: positive and negative effects on presentation of the tetanus toxin antigen via the murine B cell isoform of FcγRII. Eur. J. Immunol. 32, 530-540 (2002).
28. Bonifaz, L. C. et al. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J. Exp. Med. 199, 815-824 (2004).
29. Leung, C. S. et al. Robust T-cell stimulation by Epstein-Barr virus-transformed B cells after antigen targeting to DEC-205. Blood 121, 1584-1594 (2013).
30. Stuart, L. M. & Ezekowitz, R. A. Phagocytosis: elegant complexity. Immunity 22, 539-550 (2005).
31. Bonaccorsi, I. et al. Membrane transfer from tumor cells overcomes deficient phagocytic ability of plasmacytoid dendritic cells for the acquisition and presentation of tumor antigens. J. Immunol. 192, 824-832 (2014).
32. Steinman, R. M., Turley, S., Mellman, I. & Inaba, K. The induction of tolerance by dendritic cells that have captured apoptotic cells. J. Exp. Med. 191, 411-416 (2000).
33. Tse, S. M. et al. Differential role of actin, clathrin, and dynamin in Fcγ receptor-mediated endocytosis and phagocytosis. J. Biol. Chem. 278, 3331-3338 (2003).
34. Guermonprez, P. et al. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells. Nature 425, 397-402 (2003).
35. Houde, M. et al. Phagosomes are competent organelles for antigen cross-presentation. Nature 425, 402-406 (2003).
36. Joffre, O. P., Segura, E., Savina, A. & Amigorena, S. Cross-presentation by dendritic cells. Nature Rev. Immunol. 12, 557-569 (2012).
37. Blander, J. M. & Medzhitov, R. Regulation of phagosome maturation by signals from toll-like receptors. Science 304, 1014-1018 (2004).
38. Blander, J. M. & Medzhitov, R. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 440, 808-812 (2006).
39. Russell, D. G. & Yates, R. M. TLR signalling and phagosome maturation: an alternative viewpoint. Cell. Microbiol. 9, 849-850 (2007).
40. Mantegazza, A. R. et al. Adaptor protein-3 in dendritic cells facilitates phagosomal toll-like receptor signaling and antigen presentation to CD4+ T cells. Immunity 36, 782-794 (2012).
41. Hoffmann, E. et al. Autonomous phagosomal degradation and antigen presentation in dendritic cells. Proc. Natl Acad. Sci. USA 109, 14556-14561 (2012).
42. Mantegazza, A. R. et al. TLR-dependent phagosome tubulation in dendritic cells promotes phagosome cross-talk to optimize MHC-II antigen presentation. Proc. Natl Acad. Sci. USA 111, 15508-15513 (2014).
43. Adamopoulou, E. et al. Exploring the MHC-peptide matrix of central tolerance in the human thymus. Nature Commun. 4, 2039 (2013).
44. Crotzer, V. L. & Blum, J. S. Autophagy and adaptive immunity. Immunology 131, 9-17 (2010).
45. Schmid, D., Pypaert, M. & Munz, C. Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes. Immunity 26, 79-92 (2007).
46. Paludan, C. et al. Endogenous MHC class II processing of a viral nuclear antigen after autophagy. Science 307, 593-596 (2005).
47. Ireland, J. M. & Unanue, E. R. Autophagy in antigen-presenting cells results in presentation of citrullinated peptides to CD4 T cells. J. Exp. Med. 208, 2625-2632 (2011).
48. Wegner, N. et al. Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunol. Rev. 233, 34-54 (2010).
49. Nedjic, J., Aichinger, M., Emmerich, J., Mizushima, N. & Klein, L. Autophagy in thymic epithelium shapes the T-cell repertoire and is essential for tolerance. Nature 455, 396-400 (2008).
50. Aichinger, M., Wu, C., Nedjic, J. & Klein, L. Macroautophagy substrates are loaded onto MHC class II of medullary thymic epithelial cells for central tolerance. J. Exp. Med. 210, 287-300 (2013).
51. Lee, H. K. et al. In vivo requirement for Atg5 in antigen presentation by dendritic cells. Immunity 32, 227-239 (2010).
52. Manoury, B. et al. Asparagine endopeptidase can initiate the removal of the MHC class II invariant chain chaperone. Immunity 18, 489-498 (2003).
53. Shi, G. P. et al. Cathepsin S required for normal MHC class II peptide loading and germinal center development. Immunity 10, 197-206 (1999).
54. Nakagawa, T. Y. et al. Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice. Immunity 10, 207-217 (1999).
55. Lautwein, A. et al. Inflammatory stimuli recruit cathepsin activity to late endosomal compartments in human dendritic cells. Eur. J. Immunol. 32, 3348-3357 (2002).
56. Trombetta, E. S., Ebersold, M., Garrett, W., Pypaert, M. & Mellman, I. Activation of lysosomal function during dendritic cell maturation. Science 299, 1400-1403 (2003).
57. Inaba, K. et al. The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli. J. Exp. Med. 191, 927-936 (2000).
58. Turley, S. J. et al. Transport of peptide-MHC class II complexes in developing dendritic cells. Science 288, 522-527 (2000).
59. Manoury, B. et al. Destructive processing by asparagine endopeptidase limits presentation of a dominant T cell epitope in MBP. Nature Immunol. 3, 169-174 (2002).
60. Delamarre, L., Pack, M., Chang, H., Mellman, I. & Trombetta, E. S. Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science 307, 1630-1634 (2005).
61. Chatterjee, B. et al. Internalization and endosomal degradation of receptor-bound antigens regulate the efficiency of cross presentation by human dendritic cells. Blood 120, 2011-2020 (2012).
62. Savina, A. et al. The small GTPase Rac2 controls phagosomal alkalinization and antigen crosspresentation selectively in CD8+ dendritic cells. Immunity 30, 544-555 (2009).
63. Romao, S. et al. Autophagy proteins stabilize pathogen-containing phagosomes for prolonged MHC II antigen processing. J. Cell Biol. 203, 757-766 (2013).
64. Reith, W., LeibundGut-Landmann, S. & Waldburger, J. M. Regulation of MHC class II gene expression by the class II transactivator. Nature Rev. Immunol. 5, 793-806 (2005).
65. Steimle, V., Siegrist, C. A., Mottet, A., Lisowska-Grospierre, B. & Mach, B. Regulation of MHC class II expression by interferon-γ mediated by the transactivator gene CIITA. Science 265, 106-109 (1994).
66. Wilson, N. S., El-Sukkari, D. & Villadangos, J. A. Dendritic cells constitutively present self antigens in their immature state in vivo and regulate antigen presentation by controlling the rates of MHC class II synthesis and endocytosis. Blood 103, 2187-2195 (2004).
67. Young, L. J. et al. Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cells. Nature Immunol. 9, 1244-1252 (2008).
68. LeibundGut-Landmann, S., Waldburger, J. M., Reis e Sousa, C., Acha-Orbea, H. & Reith, W. MHC class II expression is differentially regulated in plasmacytoid and conventional dendritic cells. Nature Immunol. 5, 899-908 (2004).
69. Villadangos, J. A. & Young, L. Antigen-presentation properties of plasmacytoid dendritic cells. Immunity 29, 352-361 (2008).
70. Villadangos, J. A., Schnorrer, P. & Wilson, N. S. Control of MHC class II antigen presentation in dendritic cells: a balance between creative and destructive forces. Immunol. Rev. 207, 191-205 (2005).
71. Kleijmeer, M. J. et al. MHC class II compartments and the kinetics of antigen presentation in activated mouse spleen dendritic cells. J. Immunol. 154, 5715-5724 (1995).
72. Harding, C. V. & Geuze, H. J. Class II MHC molecules are present in macrophage lysosomes and phagolysosomes that function in the phagocytic processing of Listeria monocytogenes for presentation to T cells. J. Cell Biol. 119, 531-542 (1992).
73. Kleijmeer, M. J., Oorschot, V. M. & Geuze, H. J. Human resident langerhans cells display a lysosomal compartment enriched in MHC class II. J. Invest. Dermatol. 103, 516-523 (1994).
74. Pierre, P. et al. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 388, 787-792 (1997).
75. ten Broeke, T., van Niel, G., Wauben, M. H., Wubbolts, R. & Stoorvogel, W. Endosomally stored MHC class II does not contribute to antigen presentation by dendritic cells at inflammatory conditions. Traffic 12, 1025-1036 (2011).
76. Cella, M., Engering, A., Pinet, V., Pieters, J. & Lanzavecchia, A. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388, 782-787 (1997).
77. Kleijmeer, M. et al. Reorganization of multivesicular bodies regulates MHC class II antigen presentation by dendritic cells. J. Cell Biol. 155, 53-63 (2001).
78. Boes, M. et al. T.Cell engagement of dendritic cells rapidly rearranges MHC class II transport. Nature 418, 983-988 (2002).
79. Chow, A., Toomre, D., Garrett, W. & Mellman, I. Dendritic cell maturation triggers retrograde MHC class II transport from lysosomes to the plasma membrane. Nature 418, 988-994 (2002).
80. Lankar, D. et al. Dynamics of major histocompatibility complex class II compartments during B cell receptormediated cell activation. J. Exp. Med. 195, 461-472 (2002).
81. Siemasko, K., Eisfelder, B. J., Williamson, E., Kabak, S. & Clark, M. R. Signals from the B lymphocyte antigen receptor regulate MHC class II containing late endosomes. J. Immunol. 160, 5203-5208 (1998).
82. Vascotto, F. et al. The actin-based motor protein myosin II regulates MHC class II trafficking and BCR-driven antigen presentation. J. Cell Biol. 176, 1007-1019 (2007).
83. Le Roux, D. et al. Syk-dependent actin dynamics regulate endocytic trafficking and processing of antigens internalized through the B.cell receptor. Mol. Biol. Cell 18, 3451-3462 (2007).
84. Nashar, T. O. & Drake, J. R. The pathway of antigen uptake and processing dictates MHC class II.mediated B cell survival and activation. J. Immunol. 174, 1306-1316 (2005).
85. Mohan, J. F., Calderon, B., Anderson, M. S. & Unanue, E. R. Pathogenic CD4+ T cells recognizing an unstable peptide of insulin are directly recruited into islets bypassing local lymph nodes. J. Exp. Med. 210, 2403-2414 (2013).
86. Amigorena, S., Drake, J. R., Webster, P. & Mellman, I. Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes. Nature 369, 113-120 (1994).
87. Yuseff, M. I. et al. Polarized secretion of lysosomes at the B cell synapse couples antigen extraction to processing and presentation. Immunity 35, 361-374 (2011).
88. Rocha, N. & Neefjes, J. MHC class II molecules on the move for successful antigen presentation. EMBO J. 27, 1-5 (2008).
89. Kamon, H. et al. TRIF.GEFH1.RhoB pathway is involved in MHCII expression on dendritic cells that is critical for CD4 T.Cell activation. EMBO J. 25, 4108-4119 (2006).
90. Ocana-Morgner, C., Wahren, C. & Jessberger, R. SWAP.70 regulates RhoA/RhoB-dependent MHCII surface localization in dendritic cells. Blood 113, 1474.1482 (2009).
91. Paul, P. et al. A genome-wide multidimensional RNAi screen reveals pathways controlling MHC class II antigen presentation. Cell 145, 268-283 (2011).
92. Thery, C. et al. Indirect activation of naive CD4+ T cells by dendritic cell-derived exosomes. Nature Immunol. 3, 1156-1162 (2002).
93. Segura, E. et al. ICAM.1 on exosomes from mature dendritic cells is critical for efficient naive T.Cell priming. Blood 106, 216-223 (2005).
94. Muntasell, A., Berger, A. C. & Roche, P. A. T cell-induced secretion of MHC class II.peptide complexes on B cell exosomes. EMBO J. 26, 4263-4272 (2007).
95. Buschow, S. I. et al. MHC II in dendritic cells is targeted to lysosomes or T cell-induced exosomes via distinct multivesicular body pathways. Traffic 10, 1528-1542 (2009).
96. Bastos-Amador, P. et al. Capture of cell-derived microvesicles (exosomes and apoptotic bodies) by human plasmacytoid dendritic cells. J. Leukocyte Biol. 91, 751-758 (2012).
97. Denzer, K. et al. Follicular dendritic cells carry MHC class II.expressing microvesicles at their surface. J. Immunol. 165, 1259-1265 (2000).
98. Viaud, S. et al. Dendritic cell-derived exosomes for cancer immunotherapy: what?fs next? Cancer Res. 70, 1281-1285 (2010).
99. Zitvogel, L. et al. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cellderived exosomes. Nature Med. 4, 594-600 (1998).
100. Mahaweni, N. M., Kaijen-Lambers, M. E., Dekkers, J., Aerts, J. G. & Hegmans, J. P. Tumour-derived exosomes as antigen delivery carriers in dendritic cellbased immunotherapy for malignant mesothelioma. J. Extracell. Vesicles 2, 22492 (2013).
101. Anderson, H. A. & Roche, P. A. MHC class II association with lipid rafts on the antigen presenting cell surface. Biochim. Biophys. Acta http://dx.doi. org/10.1016/j.bbamcr.2014.09.019 (2014).
102. Kropshofer, H. et al. Tetraspan microdomains distinct from lipid rafts enrich select peptide-MHC class II complexes. Nature Immunol. 3, 61-68 (2002).
103. Anderson, H. A., Hiltbold, E. M. & Roche, P. A. Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation. Nature Immunol. 1, 156-162 (2000).
104. Eren, E. et al. Location of major histocompatibility complex class II molecules in rafts on dendritic cells enhances the efficiency of T.Cell activation and proliferation. Scand. J. Immunol. 63, 7-16 (2006).
105. Bosch, B., Heipertz, E. L., Drake, J. R. & Roche, P. A. Major histocompatibility complex (MHC) class II.peptide complexes arrive at the plasma membrane in cholesterol-rich microclusters. J. Biol. Chem. 288, 13236-13242 (2013).
106. Poloso, N. J., Muntasell, A. & Roche, P. A. MHC class II molecules traffic into lipid rafts during intracellular transport. J. Immunol. 173, 4539-4546 (2004).
107. Karacsonyi, C., Knorr, R., Fulbier, A. & Lindner, R. Association of major histocompatibility complex II with cholesterol-and sphingolipid-rich membranes precedes peptide loading. J. Biol. Chem. 279, 34818-34826 (2004).
108. Poloso, N. J. & Roche, P. A. Association of MHC class II.peptide complexes with plasma membrane lipid microdomains. Curr. Opin. Immunol. 16, 103-107 (2004).
109. Steinman, R. M., Mellman, I. S., Muller, W. A. & Cohn, Z. A. Endocytosis and the recycling of plasma membrane. J. Cell Biol. 96, 1-27 (1983).
110. Momburg, F. et al. Epitope-specific enhancement of antigen presentation by invariant chain. J. Exp. Med. 178, 1453-1458 (1993).
111. Tewari, M. K., Sinnathamby, G., Rajagopal, D. & Eisenlohr, L. C. A cytosolic pathway for MHC class II.restricted antigen processing that is proteasome and TAP dependent. Nature Immunol. 6, 287-294 (2005).
112. Pinet, V., Malnati, M. S. & Long, E. O. Two processing pathways for the MHC class II.restricted presentation of exogenous influenza virus antigen. J. Immunol. 152, 4852-4860 (1994).
113. Griffin, J. P., Chu, R. & Harding, C. V. Early endosomes and a late endocytic compartment generate different peptide-class II MHC complexes via distinct processing mechanisms. J. Immunol. 158, 1523-1532 (1997).
114. Ohmura-Hoshino, M. et al. Inhibition of MHC class II expression and immune responses by c.MIR. J. Immunol. 177, 341-354 (2006).
115. Shin, J. S. et al. Surface expression of MHC class II in dendritic cells is controlled by regulated ubiquitination. Nature 444, 115-118 (2006).
116. van Niel, G. et al. Dendritic cells regulate exposure of MHC class II at their plasma membrane by oligoubiquitination. Immunity 25, 885-894 (2006).
117. Matsuki, Y. et al. Novel regulation of MHC class II function in B cells. EMBO J. 26, 846-854 (2007).
118. De Gassart, A. et al. MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation. Proc. Natl Acad. Sci. USA 105, 3491-3496 (2008).
119. Walseng, E. et al. Ubiquitination regulates MHC class II.peptide complex retention and degradation in dendritic cells. Proc. Natl Acad. Sci. USA 107, 20465-20470 (2010).
120. Gauvreau, M. E. et al. Sorting of MHC class II molecules into exosomes through a ubiquitinindependent pathway. Traffic 10, 1518-1527 (2009).
121. Furuta, K., Ishido, S. & Roche, P. A. Encounter with antigen-specific primed CD4 T cells promotes MHC class II degradation in dendritic cells. Proc. Natl Acad. Sci. USA 109, 19380-19385 (2012).
122. Bartee, E., Mansouri, M., Hovey Nerenberg, B. T., Gouveia, K. & Fruh, K. Downregulation of major histocompatibility complex class I by human ubiquitin ligases related to viral immune evasion proteins. J. Virol. 78, 1109-1120 (2004).
123. Oh, J. et al. MARCH1.mediated MHCII ubiquitination promotes dendritic cell selection of natural regulatory T cells. J. Exp. Med. 210, 1069-1077 (2013).
124. Baravalle, G. et al. Ubiquitination of CD86 is a key mechanism in regulating antigen presentation by dendritic cells. J. Immunol. 187, 2966-2973 (2011).
125. Corcoran, K. et al. Ubiquitin-mediated regulation of CD86 protein expression by the ubiquitin ligase membrane-associated RING.CH.1 (MARCH1). J. Biol. Chem. 286, 37168-37180 (2011).
126. Thibodeau, J. et al. Interleukin.10.induced MARCH1 mediates intracellular sequestration of MHC class II in monocytes. Eur. J. Immunol. 38, 1225-1230 (2008).
127. Koppelman, B., Neefjes, J. J., de Vries, J. E. & de Waal Malefyt, R. Interleukin.10 down-regulates MHC class II À-peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling. Immunity. 7, 861-871 (1997).
128. Walseng, E. et al. Dendritic cell activation prevents MHC class II ubiquitination and promotes MHC class II survival regardless of the activation stimulus. J. Biol. Chem. 285, 41749-41754 (2010).
129. Jabbour, M., Campbell, E. M., Fares, H. & Lybarger, L. Discrete domains of MARCH1 mediate its localization, functional interactions, and posttranscriptional control of expression. J. Immunol. 183, 6500-6512 (2009).
130. Bourgeois-Daigneault, M. C. & Thibodeau, J. Autoregulation of MARCH1 expression by dimerization and autoubiquitination. J. Immunol. 188, 4959-4970 (2012).
131. Furuta, K., Walseng, E. & Roche, P. A. Internalizing MHC class II-peptide complexes are ubiquitinated in early endosomes and targeted for lysosomal degradation. Proc. Natl Acad. Sci. USA 110, 20188-20193 (2013).
132. Tze, L. E. et al. CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10-driven MARCH1-mediated ubiquitination and degradation. J. Exp. Med. 208, 149-165 (2011).
133. Klein, E. et al. CD83 localization in a recycling compartment of immature human monocyte-derived dendritic cells. Int. Immunol. 17, 477-487 (2005).
134. Bourgeois-Daigneault, M. C. & Thibodeau, J. Identification of a novel motif that affects the conformation and activity of the MARCH1 E3 ubiquitin ligase. J. Cell Sci. 126, 989-998 (2013).
135. Ma, J. K., Platt, M. Y., Eastham-Anderson, J., Shin, J. S. & Mellman, I. MHC class II distribution in dendritic cells and B cells is determined by ubiquitin chain length. Proc. Natl Acad. Sci. USA 109, 8820-8827 (2012).
136. MacGurn, J. A., Hsu, P. C. & Emr, S. D. Ubiquitin and membrane protein turnover: from cradle to grave. Annu. Rev. Biochem. 81, 231-259 (2012).
137. Tortorella, D., Gewurz, B. E., Furman, M. H., Schust, D. J. & Ploegh, H. L. Viral subversion of the immune system. Annu. Rev. Immunol. 18, 861-926 (2000).
138. Lapaque, N. et al. Salmonella regulates polyubiquitination and surface expression of MHC class II antigens. Proc. Natl Acad. Sci. USA 106, 14052-14057 (2009).
139. Wilson, J. E., Katkere, B. & Drake, J. R. Francisella tularensis induces ubiquitin-dependent major histocompatibility complex class II degradation in activated macrophages. Infect. Immun. 77, 4953-4965 (2009).
140. Hunt, D. et al. Francisella tularensis elicits IL-10 via a PGE2-inducible factor, to drive macrophage MARCH1 expression and class II down-regulation. PLoS ONE 7, e37330 (2012).
141. Ferrari, G., Langen, H., Naito, M. & Pieters, J. A coat protein on phagosomes involved in the intracellular survival of mycobacteria. Cell 97, 435-447 (1999).
142. Ramachandra, L., Noss, E., Boom, W. H. & Harding, C. V. Processing of Mycobacterium tuberculosis antigen 85B involves intraphagosomal formation of peptide-major histocompatibility complex II complexes and is inhibited by live bacilli that decrease phagosome maturation. J. Exp. Med. 194, 1421-1432 (2001).
143. Gutierrez, M. G. et al. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 119, 753-766 (2004).
144. Lilley, B. N. & Ploegh, H. L. Viral modulation of antigen presentation: manipulation of cellular targets in the ER and beyond. Immunol. Rev. 207, 126-144 (2005).
145. Tomazin, R. et al. Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells. Nature Med. 5, 1039-1043 (1999).
146. Hegde, N. R. et al. Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation. J. Virol. 76, 10929-10941 (2002).
147. Odeberg, J., Plachter, B., Branden, L. & Soderberg-Naucler, C. Human cytomegalovirus protein pp65 mediates accumulation of HLA-DR in lysosomes and destruction of the HLA-DR α-chain. Blood 101, 4870-4877 (2003).
148. Temme, S., Eis-Hubinger, A. M., McLellan, A. D. & Koch, N. The herpes simplex virus-1 encoded glycoprotein B diverts HLA-DR into the exosome pathway. J. Immunol. 184, 236-243 (2010).
149. Toussaint, H. et al. Human immunodeficiency virus type 1 nef expression prevents AP-2-mediated internalization of the major histocompatibility complex class II-associated invariant chain. J. Virol. 82, 8373-8382 (2008).
150. Stumptner-Cuvelette, P. et al. Human immunodeficiency virus-1 Nef expression induces intracellular accumulation of multivesicular bodies and major histocompatibility complex class II complexes: potential role of phosphatidylinositol 3-kinase. Mol. Biol. Cell 14, 4857-4870 (2003).
151. Zuo, J. et al. Epstein-Barr virus evades CD4+ T cell responses in lytic cycle through BZLF1-mediated downregulation of CD74 and the cooperation of vBcl-2. PLoS Pathog. 7, e1002455 (2011).
152. Ressing, M. E. et al. Epstein-Barr virus gp42 is posttranslationally modified to produce soluble gp42 that mediates HLA class II immune evasion. J. Virol. 79, 841-852 (2005).